These observations render TNF-α and adiponectin as potentially diagnostic biomarkers and appealing therapeutic targets in the setting of NAFLD-associated HCC, possibly in combination with systematic therapy. The gene discussed is ADIPOQ; the disease is hepatocellular carcinoma.